for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Stryker Corporation

SYK.N

Latest Trade

206.25USD

Change

3.09(+1.52%)

Volume

491,093

Today's Range

203.60

 - 

206.46

52 Week Range

144.77

 - 

223.37

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
203.16
Open
204.38
Volume
491,093
3M AVG Volume
26.11
Today's High
206.46
Today's Low
203.60
52 Week High
223.37
52 Week Low
144.77
Shares Out (MIL)
374.37
Market Cap (MIL)
77,213.15
Forward P/E
25.07
Dividend (Yield %)
1.01

Next Event

Q4 2019 Stryker Corp Earnings Release

Latest Developments

More

Stryker Reports Third Quarter Adjusted Earnings Per Share Of $1.91

Conformis And Stryker Execute Development, License And Distribution Agreements

Stryker Announces Definitive Agreement To Acquire Mobius Imaging & Cardan Robotics

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company's products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.

Industry

Medical Equipment & Supplies

Contact Info

2825 Airview Blvd

+1.269.3892600

https://www.stryker.com/

Executive Leadership

Kevin A. Lobo

Chairman of the Board, Chief Executive Officer

Timothy J. Scannell

President, Chief Operating Officer

Glenn S. Boehnlein

Chief Financial Officer, Vice President

Viju S. Menon

Group President - Global Quality and Operations

M. Kathryn Fink

Chief Human Resource Officer, Vice President

Key Stats

1.93 mean rating - 28 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

11.3K

2017

12.4K

2018

13.6K

2019(E)

14.9K
EPS (USD)

2016

5.800

2017

6.490

2018

7.310

2019(E)

8.228
Price To Earnings (TTM)
41.96
Price To Sales (TTM)
5.31
Price To Book (MRQ)
6.27
Price To Cash Flow (TTM)
29.40
Total Debt To Equity (MRQ)
68.33
LT Debt To Equity (MRQ)
64.06
Return on Investment (TTM)
9.18
Return on Equity (TTM)
7.66

Latest News

Latest News

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

Stryker boosts bone implants with $4 billion Wright Medical buyout

Medical device maker Stryker Corp <SYK.N> said on Monday it would buy smaller rival Wright Medical Group <WMGI.O> for about $4 billion (£3.1 billion) in cash, expanding into the fast-growing business of implants for shoulders and wrists.

Medical device maker Stryker to buy Wright Medical for $4 bln

Medical device maker Stryker Corp said on Monday it would buy smaller rival Wright Medical Group for about $4 billion in cash.

Stryker to pay $7.8 mln to settle Foreign Corrupt Practices Act charges

Medical device company Stryker Corp. will pay $7.8 million to settle charges it violated the Foreign Corrupt Practices Act, without admitting or denying the allegations, the top U.S. securities regulator said on Friday.

Medical device maker Stryker to buy K2M Group for about $1.4 billion

Medical device maker Stryker Corp <SYK.N> said on Thursday it will buy smaller rival K2M Group Holdings Inc <KTWO.O> for about $1.4 billion, adding K2M's fast-growing spinal implant technology to its business.

Stryker to buy K2M Group Holdings for about $1.4 billion

Medical device maker Stryker Corp said on Thursday it will buy smaller rival K2M Group Holdings Inc for about $1.4 billion to tap into spinal device market.

Medical device maker Stryker says not in talks to buy Boston Scientific

Medical device maker Stryker Corp <SYK.N> is not in talks to buy rival Boston Scientific Corp <BSX.N>, the company said in a regulatory filing https://bit.ly/2Jy6VQB on Wednesday, two days after a media report of a potential deal between the two surfaced.

Medical device maker Stryker says not in talks to buy Boston Scientific

Medical device maker Stryker Corp was not in discussions to buy rival Boston Scientific Corp, Stryker said in a regulatory filing https://bit.ly/2Jy6VQB on Wednesday.

Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ

Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street Journal reported on Monday, a combination that would give Stryker a strong position in stroke-preventing heart products.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Device maker Stryker has made a takeover approach to Boston Scientific - WSJ

Device maker Stryker Corp has made a takeover approach to Boston Scientific Corp, the Wall Street Journal reported https://www.wsj.com/articles/stryker-has-made-a-takeover-approach-to-boston-scientific-1528727749?mod=searchresults&page=1&pos=1, citing sources.

BRIEF-Stryker Corp Q1 Earnings Per Share $1.16

* Q1 EARNINGS PER SHARE VIEW $1.60 -- THOMSON REUTERS I/B/E/S

BRIEF-Stryker Announces Organizational Changes

* STRYKER ANNOUNCES ORGANIZATIONAL CHANGES: LONNY J. CARPENTER TO RETIRE Source text for Eikon: Further company coverage:

BRIEF-Stryker Corp Says CEO Kevin A. Lobo's 2017 Total Compensation Was $14 Million

* STRYKER CORP SAYS CEO KEVIN A. LOBO'S 2017 TOTAL COMPENSATION WAS $14 MILLION VERSUS $12.8 MILLION IN 2016 – SEC FILING Source text - http://bit.ly/2pzNhb9 Further company coverage:

BRIEF-Stryker's Spine Division Receives FDA Clearance For 3D-Printed Tritanium Tl Curved Posterior Lumbar Cage

* STRYKER'S SPINE DIVISION RECEIVES FDA CLEARANCE FOR 3D-PRINTED TRITANIUM TL CURVED POSTERIOR LUMBAR CAGE

BRIEF-Reg-Stryker Corp Announces Pricing Of $600 Million Senior Notes Offering

* REG-STRYKER CORPORATION ANNOUNCES PRICING OF $600 MILLION SENIOR NOTES OFFERING

BRIEF-Stryker Says Holds 95 Pct In Vexim; Intends To File Public Buy-Out Offer

* STRYKER CROSSES THE 95% THRESHOLDS IN VEXIM AND ANNOUNCES ITS INTENTION TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR THE OUTSTANDING SHARES OF VEXIM

BRIEF-Stryker Crosses 95 Pct Thresholds In Vexim

* CROSSED 95 PCT THRESHOLDS IN VEXIM & INTENDS TO FILE A PROPOSED PUBLIC BUY-OUT OFFER FOLLOWED BY A SQUEEZE-OUT FOR OUTSTANDING SHARES OF VEXIM

BRIEF-Stryker Declares $0.47 Per Share Quarterly Dividend

* REG-STRYKER DECLARES A $0.47 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:

BRIEF-Stryker Reports Q4 Earnings Per Share $1.21

* Q4 EARNINGS PER SHARE VIEW $1.95 -- THOMSON REUTERS I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up